Company profile for InMed Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

InMed is a biopharmaceutical company that specializes in the discovery and development of novel, cannabinoid-based therapeutics for the treatment of diseases with high unmet medical need. InMed employs a highly scientific approach to designing and developing medicines, which will help unlock the full potential of cannabinoid pharmaceuticals. One proprietary technology is our bioinformatics platform, which uses a computer-based...
InMed is a biopharmaceutical company that specializes in the discovery and development of novel, cannabinoid-based therapeutics for the treatment of diseases with high unmet medical need. InMed employs a highly scientific approach to designing and developing medicines, which will help unlock the full potential of cannabinoid pharmaceuticals. One proprietary technology is our bioinformatics platform, which uses a computer-based drug candidate selection process to reach high-probability conclusions from massive, publicly available databases together with an internal library of cannabinoid drug information.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
#310-815 West Hastings St., Vancouver BC, V6C 1B4
Telephone
Telephone
1 (604) 669-7207
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/sponsored/inmeds-inm-901-demonstrates-potential-multi-factorial-approach-treating-alzheimers

FIERCE BIOTECH
23 Jul 2024

https://www.globenewswire.com/news-release/2023/02/17/2610993/36215/en/InMed-Reports-Second-Quarter-Fiscal-2023-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
17 Feb 2023
InMed Submits Form 12b-25
InMed Submits Form 12b-25

09 Feb 2023

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2023/02/10/2605621/36215/en/InMed-Submits-Form-12b-25.html

GLOBENEWSWIRE
09 Feb 2023

https://www.globenewswire.com/news-release/2023/01/10/2586035/36215/en/InMed-Provides-Business-Update-and-Milestones-for-2023.html

GLOBENEWSWIRE
10 Jan 2023

https://www.globenewswire.com/news-release/2022/12/15/2575160/36215/en/InMed-Announces-Results-of-2022-Annual-General-Meeting.html

GLOBENEWSWIRE
15 Dec 2022

https://www.globenewswire.com//news-release/2022/12/12/2572311/36215/en/InMed-Announces-Appointment-of-Interim-Chief-Financial-Officer-and-Change-of-Auditor.html

GLOBENEWSWIRE
12 Dec 2022

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty